Insights
Perspectives on MedTech commercial strategy, M&A, regulatory change, and market dynamics across EMEA.
5 Mistakes MedTech Companies Make Entering the Nordic Market
The Nordics look deceptively simple. Similar languages, high GDP, universal healthcare. But the commercial reality is more complex than most MedTech companies expect.
MDR is Reshaping European MedTech Distribution. Here is How.
The European Medical Device Regulation is not just a compliance exercise. It is fundamentally changing which products reach the market and through which channels.
Why Your MedTech PE Deal Needs Commercial Due Diligence
Financial models tell you what happened. Commercial due diligence tells you whether it will continue. For MedTech acquisitions, the difference is material.
Interim vs. Full-Time: When to Use a Fractional CCO
Not every commercial leadership gap requires a permanent hire. Understanding when interim or fractional executives make sense can save time, money, and organizational energy.
AI in MedTech: Commercialization is the Hard Part
The technology works. The clinical evidence is growing. But most AI-enabled medical devices struggle with the same challenge: getting someone to pay for them.